摘要
院内中药制剂是中医临床的中坚力量,是传承中医药的载体和中医药特色学科建设重要支撑,更是中医药实现价值的现代手段。现行相关法规对院内中药制剂的定位不准确,监管不合理,定价制度不能体现其内在价值,制约了院内中药制剂的发展。
Hospital Chinese drugs preparation is the backbone of the Chinese medical clinical practice.It is an inheritance carrier of traditional Chinese medicine(TCM) and an important support of the traditional Chinese medical characteristic discipline construction.The hospital Chinese drugs preparation is also a modern way to realize the value of TCM.But current relevant rules are unreasonable and inaccurate,which become an obstacle to the development of hospital preparation.Meanwhile,the price system cannot embody the intrinsic value of hospital Chinese drugs preparation.
出处
《世界科学技术-中医药现代化》
北大核心
2012年第3期1732-1735,共4页
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金
上海市卫生局项目(2010207):运用知识产权促进上海传统医药发展的策略研究
负责人:宋晓亭
上海市中医药发展办公室项目(2010G002A):运用知识产权促进上海传统医药发展策略研究
负责人:宋晓亭
关键词
院内制剂
院内中药制剂
地位
制度障碍
Hospital preparation
hospital Chinese drugs preparation
role
systematic obstacles